This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

ACTH

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

ACTH belongs to the lipotrophin family of peptides which includes alpha-MSH and beta-endorphins. It is synthesised by corticotroph cells in the anterior and intermediate lobes of the pituitary from a large precursor molecule POMC - pro -opiomelanocortin.

Release of ACTH is controlled by:

  • stimuli - corticotrophin-releasing factor, vasopressin, IL-1, catecholamines, physical or mental stress
  • inhibitor - cortisol, by both a feedback loop to hypothalamus and pituitary

Patterns of ACTH secretion:

  • 24 - hour rhythm - lowest levels during the early hours of sleep; peak levels just prior to waking
  • episodes of secretion at meal times and every 1-3 hours

Effects of ACTH include:

  • glucocorticoid production by the innermost layers of the adrenal cortex:
    • increases cAMP within cells that:
      • decreases cholesterol breakdown and increases cholesterol uptake from the blood
      • activates the rate-limiting enzymes at the start of the steroid biosynthetic pathway
      • cortisol production commences within minutes of an intravenous dose
  • minimal melanocyte stimulating hormone activity and has the ability to stimulate melanocytes if secreted in excess
  • minimal release of aldosterone and sex steroids from adrenal cortex

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.